Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

777 Press Releases
DateTitleCompany
06 Jan 14 Merck to Hold Fourth-Quarter 2013 Sales and Earnings Conference Call on February 5 Merck,
Published by
Business Wire
18 Dec 13 Merck Collaborates with GlaxoSmithKline to Evaluate Novel Combination Regimen for Advanced Renal Cell Carcinoma Merck,
Published by
Business Wire
13 Dec 13 Merck Statement on FDA Advisory Committee for GRASTEK® (Timothy Grass Pollen Allergen Extract), Merck’s Investigational Sublingual Allergy Immunotherapy Tablet Merck,
Published by
Business Wire
26 Nov 13 Merck Announces Increased Quarterly Dividend Merck,
Published by
Business Wire
21 Nov 13 Merck Consumer Health Turnaround on Track Merck,
Published by
Business Wire
15 Nov 13 Interim Data to Be Presented for MK-3475, Merck’s Investigational Anti-PD-1 Immunotherapy, in Patients with Advanced Melanoma Merck,
Published by
Business Wire
24 Oct 13 Merck Provides Update on Investigational 9-valent HPV Vaccine V503 to U.S. Advisory Committee on Immunization Practices Merck,
Published by
Business Wire
23 Oct 13 ZOSTAVAX® (Zoster Vaccine Live) Awarded Prix Galien USA 2013 Best Biotechnology Product Merck,
Published by
Business Wire
22 Oct 13 Merck Receives Breakthrough Therapy Designation for MK-5172/MK-8742, an Investigational Oral Combination Regimen for the Treatment of Chronic Hepatitis C Virus (HCV) Infection Merck,
Published by
Business Wire
07 Oct 13 Merck Serono Makes First Awards as Part of the Company’s €1 Million Grant for Multiple Sclerosis Innovation Merck Serono
07 Oct 13 Merck Announce Cut of 8,500 Jobs Merck,
Published by
Pharmiweb.com
01 Oct 13 Interim Data for Merck’s MK-3475, an Investigational Anti-PD-1 Immunotherapy, in Previously Treated Patients with Non-Small Cell Lung Cancer to be Presented at 15th World Conference on Lung Cancer Merck,
Published by
Business Wire
01 Oct 13 Data from Merck’s Investigational Hepatitis C Treatment Portfolio to be Presented at the 64th American Association for the Study of Liver Diseases Annual Meeting Merck,
Published by
Business Wire
01 Oct 13 Merck Serono's Erbitux Significantly Extends Survival by 7.5 Months in mCRC RAS Wild-Type Patients When Compared With Bevacizumab: New Analysis of FIRE-3 AIO Study Merck Serono,
Published by
AxonComms
01 Oct 13 Merck Updates Plans for Headquarters Move in New Jersey Merck,
Published by
Business Wire
27 Sep 13 Merck to Hold Third-Quarter 2013 Sales and Earnings Conference Call on October 28 Merck,
Published by
Business Wire
23 Sep 13 Merck Receives Complete Response Letter for Investigational Medicine Sugammadex Sodium Injection Merck,
Published by
Business Wire
11 Sep 13 Merck and AstraZeneca Enter License Agreement for Investigational Oral WEE1 Kinase Inhibitor Therapy for Cancer Merck,
Published by
Business Wire
09 Sep 13 Merck Announces FDA Acceptance of New Drug Application for Investigational Fertility Treatment Merck,
Published by
Business Wire
30 May 13 Merck to Present at the Sanford C. Bernstein Strategic Decisions Conference Merck,
Published by
Business Wire
24 May 13 Merck Prices $ 6.5 Billion Debt Offering Merck & Co. Inc.,
Published by
Business Wire
28 May 13 Merck Announces Third-Quarter 2013 Dividend Merck,
Published by
Business Wire
24 Jul 13 Merck Announces Fourth-Quarter 2013 Dividend Merck,
Published by
Business Wire
24 Jul 13 Merck Announces FDA Acceptance of New Drug Application for Vorapaxar, Investigational Anti-Thrombotic Medicine Merck,
Published by
Business Wire
30 Jul 13 Merck Applauds Colombia for First PAHO/WHO Verification of Elimination of River Blindness Merck,
Published by
Business Wire
10 Sep 13 Merck Millipore Donates $30,000 to charity: water in Recognition of World Water Week Merck Millipore,
Published by
Business Wire
03 Jun 13 Merck Announces Presentation of Interim Data from Study Evaluating Lambrolizumab, an Investigational Anti-PD-1 Antibody, in Patients with Advanced Melanoma at ASCO 2013 Merck,
Published by
Pharmiweb.com
16 Jul 13 Merck Statement on FDA Advisory Committee Meeting About Sugammadex Sodium Injection Merck,
Published by
Business Wire
01 Jul 13 Merck Receives Complete Response Letter for Suvorexant, Merck’s Investigational Medicine for Insomnia Merck,
Published by
Business Wire
28 Jun 13 Merck to Hold Second-Quarter 2013 Sales and Earnings Conference Call on July 30 Merck,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.